Teva Pharma (NYSE: TEVA) announced that it has signed a definitive agreement with Allergan plc (NYSE: AGN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Canaccord Genuity Raises Price Target on Teva Pharma (TEVA) Following Announced Acquisition of Allergan Generics July 28, 2015 9:23 AM Canaccord Genuity Raises Price Target on Allergan (AGN) Following Announced Generics Sale July 28, 2015 9:13 AM Piper Jaffray Cuts Price Target on McGraw Hill Financial (MHFI) to $114 Following 2Q EPS Beat July 28, 2015 9:05 AM Leerink Partners Raised Price Target on Allergan (AGN) to $388 Following TEVA Announcement July 28, 2015 8:19 AM Leerink Partners Raises Price Target to $84 on Teva Pharma (TEVA) Following Call with CFO July 28, 2015 8:12 AM